US20090087490A1 - Extended release formulation and method of treating adrenergic dysregulation - Google Patents

Extended release formulation and method of treating adrenergic dysregulation Download PDF

Info

Publication number
US20090087490A1
US20090087490A1 US12/134,444 US13444408A US2009087490A1 US 20090087490 A1 US20090087490 A1 US 20090087490A1 US 13444408 A US13444408 A US 13444408A US 2009087490 A1 US2009087490 A1 US 2009087490A1
Authority
US
United States
Prior art keywords
dosage form
wt
oral dosage
amount
α
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/134,444
Inventor
Henry Joseph Horacek
Min Michael He
Moise A. Khayrallah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Inc
Original Assignee
Addrenex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US94293407P priority Critical
Application filed by Addrenex Pharmaceuticals Inc filed Critical Addrenex Pharmaceuticals Inc
Priority to US12/134,444 priority patent/US20090087490A1/en
Assigned to ADDRENEX PHARMACEUTICALS, INC. reassignment ADDRENEX PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KHAYRALLAH, MOISE ANTUN, HE, MIN MICHAEL, HORACEK, HENRY JOSEPH
Publication of US20090087490A1 publication Critical patent/US20090087490A1/en
Assigned to SHIONOGI PHARMA, INC. reassignment SHIONOGI PHARMA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ADDRENEX PHARMACEUTICALS, INC.
Assigned to SHIONOGI INC. reassignment SHIONOGI INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: SHIONOGI PHARMA, INC.
Application status is Abandoned legal-status Critical

Links